Dean J Kereiakes is an expert in Cardiology at Christ Hospital (United States, Cincinnati) (United States). As of October 2026, ScienceLeadR ranks Dean J Kereiakes in the top 1% of experts worldwide for Coronary Disease, Myocardial Ischemia and Arteriosclerosis. Dean J Kereiakes has authored 870 publications, the most recent in 2026, and is an investigator in 77 clinical trials, 2 of them ongoing. SLR score: 3,454 (community average: 125). How the SLR is computed.

LeadR Profile

Dean J Kereiakes Christ Hospital (United States, Cincinnati) United States
3 454 ScienceLeadR Reputation 3454
Network Map

Cardiology

Subspecialties: Public Health - Surgery - Thoracic And Cardiovascular Surgery

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Short Biography

Dean J. Kereiakes, MD, FACC, MSCAI is Chairman of The Christ Hospital Heart and Vascular Institute, Medical Director of The Christ Hospital Research Institute, Professor of Medicine at The University of Cincinnati and Clinical Professor of Medicine at The Ohio State University. He received his medical degree and received the Stella Feis Hoffheimer Memorial Prize as valedictorian of his graduating class at the University of Cincinnati in Ohio. Post graduate training included internship and residency at the University of California, San Francisco, senior residency at Massachusetts General Hospital in Boston, and Chief Residency at the University of California, San Francisco. He completed fellowships in adult cardiology at the University of California, San Francisco and in coronary angioplasty at the San Francisco Heart Institute and the Sequoia Hospital. Dr. Kereiakes has been the national/international Principal Investigator in trials for FDA approval of more than 30 novel drugs and medical devices. He was the Founder and CEO of the largest cardiology subspecialty group in Ohio (Ohio Heart Health Center) which has become the cardiovascular service line of The Christ Hospital, Cincinnati, Ohio. He was the founder and Medical Director of The Carl & Edyth Lindner Center for Research and Education at The Christ Hospital, which is one of the top clinical research sites in the United States. His vision directed the establishment of The Lindner Heart Failure Treatment Center at The Christ Hospital in 2005, which is a 30-bed in-patient unit dedicated to the treatment of congestive heart failure. Dr. Kereiakes has performed more than 30,000 catheterization laboratory procedures, including First in Human and First in the U.S. use of novel medical devices.

Dr. Kereiakes has published over 1300 peer-reviewed scientific journal articles, abstracts, and book chapters. He previously served as Section Editor for Circulation and is currently Deputy Editor of Journal for the Society of Cardiovascular Angiography and Intervention. Dr. Kereiakes has served on the Editorial Boards of every major cardiovascular journal in the U.S. He has been recognized with the “Master” (MSCAI) distinction by The Society for Cardiovascular Angiography and Interventions and has received both the Scottsdale Interventional Forum Lifetime Achievement and the Society for Cardiovascular Angiography and Intervention Helping Hearts Lifetime Achievement Awards. He was named an Outstanding Alumnus at The University of Cincinnati College of Medicine and has received an Honorary Doctor of Science from the University of Cincinnati. Dr. Kereiakes has also received the highest level of recognition from the University of Cincinnati Alumni Association, the William Howard Taft Medal for significant achievement. He was honored with the Samuel Kaplan, M.D., Visionary Award from the American Heart Association and was selected for the Cincinnati Business Courier Healthcare Heroes Innovator Award for both 1998 and 2025. He has been named to Best Doctors in America, Who’s Who in Medicine and Healthcare, Who’s Who in Science and Engineering, Who’s Who in America and Who’s Who in the World.


Organizations

Career arc: 1985 - 2026

Source: PubMed

Christ Hospital (United States, Cincinnati)

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 870

Citations

Citations: 123 820 1st author: 147 Last author: 110 Unique author: 65


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Evaluating Standard Shielding Versus Novel Enhanced Radiation Protection Devices in the Cardiac Catheterization Laboratory.
PMID 42857978 — heart diseases, laboratories, cardiac catheterization, radiation exposure, catheterization, radiation protection
J Am Heart Assoc20260
Transcatheter Aortic Valve Replacement in Patients With Symptomatic, Severe Aortic Regurgitation: 1-Year Outcomes of the J-Valve Transfemoral Early Feasibility Study.
PMID 42769951 — mortality, feasibility studies, safety, stroke, aortic valve, aortic valve insufficiency, aortic valve disease, transcatheter aortic valve replacement
J Soc Cardiovasc Angiogr Interv20260
The Catheterization Laboratory: An Occupational Anachronism.
PMID 42769905 — laboratories, catheterization
J Soc Cardiovasc Angiogr Interv20260
Matched and Measured: An In-depth Look at the Interventional Cardiology Fellowship Match-Fellows' Perspective.
PMID 42769915 — perception, cardiology
J Soc Cardiovasc Angiogr Interv20260
Efficacy and Safety of Semaglutide According to Frailty Status: A Post Hoc Analysis of the SELECT Randomized Clinical Trial.
PMID 42747817 — glucagon-like peptide 1, quality of life, safety, cardiovascular diseases, frailty, semaglutide
JAMA Cardiol20260

Clinical Studies 77

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 7 Study Chair: 2

By phase:

Phase 3 32
N/A 23
Phase 2 9
Phase 4 8
Phase 1 2
Early Phase 1 1
Phase 1/Phase 2 1
Phase 2/Phase 3 1

By status:

Completed 64
Terminated 5
Active not recruiting 4
Recruiting 2
Suspended 1
Unknown 1

By type:

Interventional 74
Observational 3

By Monocentric/Multicentric:

monocentric 12
multicentric2to4 4
multicentric5to9 4
multicentricup10 57

Main Topics

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
J Valve Transfemoral Pivotal Study
NCT06455787 — bioprosthesis, pharmaceutical preparations, aortic valve, aortic valve insufficiency, aortic valve disease, transcatheter aortic valve replacement, drug delivery systems, therapeutics, surgical aortic valve replacement
N/ARecruiting2024
J Valve TF Early Feasibility Study
NCT06034028 — heart valve diseases, feasibility studies, heart diseases, bioprosthesis, heart, aortic valve, aortic valve insufficiency, aortic valve disease, transcatheter aortic valve replacement, heart valves
N/AActive not recruiting2023

LeadR Networks

Main global connection map